Literature DB >> 22486998

Arteriovenous fistula creation using the Optiflow vascular anastomosis device: a first in man pilot study.

Roberto J Manson1, Adrian Ebner, Santiago Gallo, Eric Chemla, Mark Mantell, David Deaton, Prabir Roy-Chaudhury.   

Abstract

Although arteriovenous fistulae are the preferred form of dialysis vascular access they continue to have significant problems with maturation failure. The Optiflow device is a sutureless anastomotic conduit which could potentially reduce surgical time and also standardize the surgical procedure. We report herein on the "First in Man" experience with the Optiflow device.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22486998     DOI: 10.1111/j.1525-139X.2012.01062.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  5 in total

Review 1.  Future research directions to improve fistula maturation and reduce access failure.

Authors:  Haidi Hu; Sandeep Patel; Jesse J Hanisch; Jeans M Santana; Takuya Hashimoto; Hualong Bai; Tambudzai Kudze; Trenton R Foster; Jianming Guo; Bogdan Yatsula; Janice Tsui; Alan Dardik
Journal:  Semin Vasc Surg       Date:  2016-08-26       Impact factor: 1.000

2.  Novel paradigms for dialysis vascular access: Introduction.

Authors:  Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2013-12       Impact factor: 8.237

Review 3.  Arteriovenous conduits for hemodialysis: how to better modulate the pathophysiological vascular response to optimize vascular access durability.

Authors:  Yan-Ting Shiu; Joris I Rotmans; Wouter Jan Geelhoed; Daniel B Pike; Timmy Lee
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-20

Review 4.  Novel therapies for hemodialysis vascular access dysfunction: myth or reality?

Authors:  Christi M Terry; Laura M Dember
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

Review 5.  Vascular access in haemodialysis: strengthening the Achilles' heel.

Authors:  Miguel C Riella; Prabir Roy-Chaudhury
Journal:  Nat Rev Nephrol       Date:  2013-04-16       Impact factor: 28.314

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.